Production (Stage)
Tonix Pharmaceuticals Holding Corp.
TNXP
$28.93
$2.539.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.83M | -22.11M | -14.21M | -78.78M | -14.94M |
| Total Depreciation and Amortization | 493.00K | 972.00K | 510.00K | 967.00K | 1.01M |
| Total Amortization of Deferred Charges | 65.00K | -276.00K | 209.00K | 367.00K | 502.00K |
| Total Other Non-Cash Items | 2.97M | 366.00K | 1.32M | 62.70M | -5.31M |
| Change in Net Operating Assets | -3.28M | 6.42M | -6.63M | 4.82M | 1.17M |
| Cash from Operations | -16.58M | -14.63M | -18.80M | -9.92M | -17.58M |
| Capital Expenditure | -6.00K | -3.00K | -9.00K | 0.00 | -108.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.00K | -3.00K | -9.00K | 0.00 | -108.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.65M | -705.00K | -705.00K | -705.00K | -235.00K |
| Issuance of Common Stock | 64.50M | 89.16M | 45.85M | 12.43M | 23.00K |
| Repurchase of Common Stock | -3.05M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.27M | -3.30M | -2.24M | -4.70M | -- |
| Cash from Financing | 49.53M | 85.15M | 42.91M | 7.03M | -212.00K |
| Foreign Exchange rate Adjustments | -9.00K | 24.00K | -17.00K | 1.00K | -4.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.94M | 70.55M | 24.08M | -2.89M | -17.90M |